BeiGene announced its financial results for the first quarter of 2026, reporting a net profit attributable to parent company owners of 1.608 billion yuan. This marks a significant turnaround from a loss in the same period last year. The company's revenue grew by 31.0% year-over-year to 10.544 billion yuan, primarily driven by strong sales of its key products, including BeiYueZe®, authorized products from Amgen, and BeiZeAn®. AI
Summary written by gemini-2.5-flash-lite from 1 source. How we write summaries →
RANK_REASON Financial results announcement from a major company. [lever_c_demoted from significant: ic=1 ai=0.1]